| Entry |
|
|---|
| Name |
Tezampanel (USAN);
Tezampanel hydrate |
|---|
| Formula |
C13H21N5O2. H2O
|
|---|
| Exact mass |
297.1801
|
|---|
| Mol weight |
297.3534
|
|---|
| Structure |
|
|---|
| Class |
Neuropsychiatric agent
DG03199 Antiepileptic agent
DG01569 AMPA receptor antagonist
|
|---|
| Efficacy |
Anticonvulsant, Pain relief, AMPA receptor antagonist, Kainate receptor antagonist |
|---|
| Comment |
Treatment of migraine, neuropathic pain
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Neuropsychiatric agent
DG03199 Antiepileptic agent
DG01569 AMPA receptor antagonist
D06656 Tezampanel
Target-based classification of drugs [BR:br08310]
Ion channels
Ligand-gated ion channels
Glutamate (ionotropic), non-NMDA
GRIA
D06656 Tezampanel (USAN)
GRIK
D06656 Tezampanel (USAN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 21
1 C1y C 24.8181 -24.4012
2 N1x N 24.8181 -25.8049
3 C1x C 26.0337 -26.5067
4 C1y C 27.2493 -25.8049
5 C1y C 27.2493 -24.4012
6 C1x C 26.0337 -23.6994
7 C1x C 28.4649 -26.5067
8 C1x C 29.6804 -25.8049
9 C1y C 29.6804 -24.4012
10 C1x C 28.4649 -23.6994
11 C6a C 23.6026 -23.6994
12 C1b C 30.8812 -23.7079
13 O6a O 22.4039 -24.3916
14 O6a O 23.6025 -22.2959
15 C1b C 32.0726 -24.3957
16 C8y C 33.2665 -23.7063
17 N5x N 34.4024 -24.5276
18 N5x N 35.5384 -23.7031
19 N5x N 35.1052 -22.3679
20 N4x N 33.7016 -22.3673
21 O0 O 33.8716 -26.9278
BOND 22
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 5 6 1
6 1 6 1
7 4 7 1
8 7 8 1
9 8 9 1
10 9 10 1
11 5 10 1
12 1 11 1 #Down
13 9 12 1 #Up
14 11 13 1
15 11 14 2
16 12 15 1
17 15 16 1
18 16 17 2
19 17 18 1
20 18 19 2
21 19 20 1
22 16 20 1
|
|---|
